Literature DB >> 17291459

Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.

Man Jiang1, Qingqing Wei, Navjotsin Pabla, Guie Dong, Cong-Yi Wang, Tianxin Yang, Sylvia B Smith, Zheng Dong.   

Abstract

Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Recent work has suggested a role of p53 in renal cell injury by cisplatin. However, the mechanism of p53 activation by cisplatin is unclear. This study determined the possible involvement of oxidative stress in p53 activation under the pathological condition using in vitro and in vivo models. In cultured renal proximal tubular cells, cisplatin at 20 microM induced an early p53 phosphorylation followed by protein accumulation. Cisplatin also induced reactive oxygen species (ROS), among which hydroxyl radicals showed a rapid and drastic accumulation. Dimethylthiourea (DMTU) and N-acetyl-cysteine (NAC) attenuated hydroxyl radical accumulation, and importantly, diminished p53 activation during cisplatin treatment. This was accompanied by the suppression of PUMA-alpha, a p53-regulated apoptotic gene. Concomitantly, mitochondrial cytochrome c release and apoptosis were ameliorated. Notably, DMTU and NAC, when added post-cisplatin treatment, were also inhibitory to p53 activation and apoptosis. In C57BL/6 mice, cisplatin at 30 mg/kg induced p53 phosphorylation and protein accumulation, which was also abrogated by DMTU. DMTU also ameliorated tissue damage, tubular cell apoptosis and cisplatin-induced renal failure. Collectively, this study has suggested a role of oxidative stress, particularly hydroxyl radicals, in cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291459      PMCID: PMC2709740          DOI: 10.1016/j.bcp.2007.01.010

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  45 in total

Review 1.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways.

Authors:  Kazuhiko Tsuruya; Masanori Tokumoto; Toshiharu Ninomiya; Makoto Hirakawa; Kohsuke Masutani; Masatomo Taniguchi; Kyoichi Fukuda; Hidetoshi Kanai; Hideki Hirakata; Mitsuo Iida
Journal:  Am J Physiol Renal Physiol       Date:  2003-04-08

3.  Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.

Authors:  Kazuhiko Tsuruya; Toshiharu Ninomiya; Masanori Tokumoto; Makoto Hirakawa; Kohsuke Masutani; Masatomo Taniguchi; Kyoichi Fukuda; Hidetoshi Kanai; Kenji Kishihara; Hideki Hirakata; Mitsuo Iida
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

4.  Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis.

Authors:  Hua Liu; Radhakrishna Baliga
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 5.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

6.  Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats.

Authors:  Kunihiko Sueishi; Kazuto Mishima; Kazutaka Makino; Yoshinori Itoh; Kazuhiko Tsuruya; Hideki Hirakata; Ryozo Oishi
Journal:  Eur J Pharmacol       Date:  2002-09-13       Impact factor: 4.432

7.  A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.

Authors:  Minoru Satoh; Naoki Kashihara; Sohachi Fujimoto; Hideyuki Horike; Takehiko Tokura; Tamehachi Namikoshi; Tamaki Sasaki; Hirofumi Makino
Journal:  J Pharmacol Exp Ther       Date:  2003-03-20       Impact factor: 4.030

Review 8.  Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.

Authors:  M A Fuertes; J Castilla; C Alonso; J M Pérez
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

9.  Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2.

Authors:  Zheng Dong; Jin Zhao Wang; Fushin Yu; Manjeri A Venkatachalam
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells.

Authors:  Grazyna Nowak
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

View more
  41 in total

1.  Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.

Authors:  Sudjit Luanpitpong; Siera Jo Talbott; Yon Rojanasakul; Ubonthip Nimmannit; Varisa Pongrakhananon; Liying Wang; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Activation and involvement of p53 in cisplatin-induced nephrotoxicity.

Authors:  Qingqing Wei; Guie Dong; Tianxin Yang; Judit Megyesi; Peter M Price; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-01

3.  A Simple Microfluidic Electrochemical HPLC Detector for Quantifying Fenton Reactivity from Welding Fumes.

Authors:  Thanakorn Pluangklang; John B Wydallis; David M Cate; Duangjai Nacapricha; Charles S Henry
Journal:  Anal Methods       Date:  2014-10-21       Impact factor: 2.896

4.  Ameliorative effect of flunarizine in cisplatin-induced acute renal failure via mitochondrial permeability transition pore inactivation in rats.

Authors:  Arunachalam Muthuraman; Shailja Sood; Sumeet Kumar Singla; Ajay Rana; Atinderjeet Singh; Amandeep Singh; Jai Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

5.  Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism.

Authors:  Sudjit Luanpitpong; Ubonthip Nimmannit; Pithi Chanvorachote; Stephen S Leonard; Varisa Pongrakhananon; Liying Wang; Yon Rojanasakul
Journal:  Apoptosis       Date:  2011-08       Impact factor: 4.677

6.  MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.

Authors:  Kirti Bhatt; Li Zhou; Qing-Sheng Mi; Shuang Huang; Jin-Xiong She; Zheng Dong
Journal:  Mol Med       Date:  2010-04-09       Impact factor: 6.354

7.  Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI.

Authors:  Rajesh K Dutta; Vinay K Kondeti; Isha Sharma; Navdeep S Chandel; Susan E Quaggin; Yashpal S Kanwar
Journal:  J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 10.121

8.  Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species.

Authors:  Daniel A Langer; Amitava Das; David Semela; Ningling Kang-Decker; Helen Hendrickson; Steven F Bronk; Zvonimir S Katusic; Gregory J Gores; Vijay H Shah
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

9.  The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.

Authors:  Navjotsingh Pabla; Robert F Murphy; Kebin Liu; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

10.  Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway.

Authors:  Man Jiang; Cong-Yi Wang; Shuang Huang; Tianxin Yang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.